ACCESS

Corporate Advisor to Epitan advice of capital raising options and placements of shares

In 2005 we assisted an ASX listed bio-tech, Epitan Limited (now called Clinuval Pharmaceuticals), in two institutional equity raisings totalling $10.4m and a related Share Purchase Plan for shareholders. The institutional raising included institutions based in both Europe and Australia.

 

Back

 
 
Copyright 2011 Kidder Williams Ltd